News
Hip implant maker claims surgical funder inflated patients' bills
The claim by DePuy Orthopaedics marks the first time that a device maker in the multibillion-dollar litigation over faulty hip replacements has publicly raised concerns about the controversial business of surgical funding, which has increasingly become a part of mass litigation over medical devices.
Surgical funders essentially invest in operations on injured plaintiffs. If a litigant can't afford surgery to correct problems allegedly caused by medical devices, the funders will step in to purchase medical bills at a deep discount from physicians, hospitals and others who have provided care to the patient. When the patient's lawsuit settles, the funder reaps a profit by placing a lien on the settlement for the full amount of the patient's surgical bill.
Following a Reuters report about the role of Texas-based medical funder Medstar in pelvic mesh litigation, DePuy Orthopaedics has raised new questions about Medstar in litigation over its all-metal ASR hip implants. Read more here.
Last modified: Thu, 26 Nov 2015 11:03:12 GMT